.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
US Army
Colorcon
Julphar
Daiichi Sankyo
Medtronic
Harvard Business School
Express Scripts
Johnson and Johnson

Generated: September 23, 2017

DrugPatentWatch Database Preview

Marksans Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for MARKSANS PHARMA, and what generic and branded alternatives to MARKSANS PHARMA drugs are available?

MARKSANS PHARMA has twelve approved drugs.



Summary for Applicant: Marksans Pharma

Patents:0
Tradenames:8
Ingredients:8
NDAs:12
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Marksans Pharma
IBUPROFEN
ibuprofen
TABLET;ORAL090796-001Dec 21, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
METFORMIN HYDROCHLORIDE
metformin hydrochloride
TABLET, EXTENDED RELEASE;ORAL090295-002Apr 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
GABAPENTIN
gabapentin
CAPSULE;ORAL090007-001Jul 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
METFORMIN HYDROCHLORIDE
metformin hydrochloride
TABLET;ORAL090888-001Mar 12, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
LORATADINE
loratadine
CAPSULE;ORAL206214-001Sep 23, 2016OTCNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
NAPROXEN
naproxen
TABLET;ORAL091416-001Feb 14, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
PARICALCITOL
paricalcitol
CAPSULE;ORAL204948-003Oct 7, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
NAPROXEN
naproxen
TABLET;ORAL091416-003Feb 14, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
METFORMIN HYDROCHLORIDE
metformin hydrochloride
TABLET, EXTENDED RELEASE;ORAL090295-001Apr 29, 2016AB1RXNoNo► Subscribe► Subscribe► Subscribe
Marksans Pharma
NAPROXEN SODIUM
naproxen sodium
TABLET;ORAL090545-001Mar 16, 2011OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Citi
Harvard Business School
Cerilliant
Chubb
Cantor Fitzgerald
QuintilesIMS
Covington
McKinsey
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot